Central Valley Advisors LLC Has $1.89 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Central Valley Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,736 shares of the healthcare conglomerate’s stock after buying an additional 222 shares during the period. Central Valley Advisors LLC’s holdings in UnitedHealth Group were worth $1,889,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of UNH. WINTON GROUP Ltd bought a new stake in UnitedHealth Group during the 2nd quarter worth approximately $228,000. Renaissance Technologies LLC bought a new stake in UnitedHealth Group in the 2nd quarter valued at $36,323,000. Sienna Gestion increased its holdings in UnitedHealth Group by 2,619.2% during the 2nd quarter. Sienna Gestion now owns 21,074 shares of the healthcare conglomerate’s stock worth $10,727,000 after purchasing an additional 20,299 shares in the last quarter. First Eagle Investment Management LLC boosted its position in shares of UnitedHealth Group by 963.5% during the second quarter. First Eagle Investment Management LLC now owns 411,381 shares of the healthcare conglomerate’s stock worth $209,500,000 after buying an additional 372,701 shares during the period. Finally, Miramar Capital LLC raised its position in UnitedHealth Group by 7.5% in the 2nd quarter. Miramar Capital LLC now owns 23,325 shares of the healthcare conglomerate’s stock valued at $11,878,000 after buying an additional 1,627 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. UBS Group reduced their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $511.02 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market cap of $470.28 billion, a PE ratio of 33.29, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The stock’s fifty day moving average price is $553.38 and its two-hundred day moving average price is $562.98.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.64%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.